Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02596932 · ClinicalTrials.gov registry record · NA
Intrapartum Glucose Management Among Women With Gestational Diabetes Mellitus
A NA study, sponsored by Women and Infants Hospital of Rhode Island.
- Completed
- Registry status
- NA
- Development phase
- 76
- Enrollment target
NCT02596932: Completed NA study, sponsored by Women and Infants Hospital of Rhode Island.
NCT02596932 is a NA study that has completed, run by Women and Infants Hospital of Rhode Island. The registered enrollment target is 76 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02596932, a NA study, has completed, sponsored by Women and Infants Hospital of Rhode Island.
- COMPLETED
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
Study Summary
Gestational Diabetes Mellitus (GDM) is one of the most common medical complications of pregnancy. Neonatal hypoglycemia is a common and well described complication for infants born to mothers with GDM and diabetes mellitus (DM) and studies have linked intrapartum maternal glucose levels with neonatal hypoglycemia. While guidelines exist to guide practitioners in how to best manage intrapartum maternal glucose levels among Type I and and Type II DM, there is a paucity of data guiding practitioners in the intrapartum management of blood glucose levels for women with GDM, particularly those treated with insulin antepartum. The goal of this project is to compare two protocols of intrapartum glucose management in women with GDM and investigate the impact on neonatal blood glucose levels.
Interventions
- OTHER Standard Protocol for intrapartum glucose management
- OTHER Experimental Protocol for intrapartum glucose management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2016-02 |
| Est. Completion | 2018-12 |
| Phase | NA |
What the finished NCT02596932 record still lists
NCT02596932 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard Protocol for intrapartum glucose management is the first listed.
NCT02596932 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02596932 about?
NCT02596932 is a clinical study titled "Intrapartum Glucose Management Among Women With Gestational Diabetes Mellitus". Gestational Diabetes Mellitus (GDM) is one of the most common medical complications of pregnancy. Neonatal hypoglycemia is a common and well described complication for infants born to mothers with GDM and diabetes mellitus (DM) and studies have linked intrapartum maternal glucose levels with neonata...
What is the current status of trial NCT02596932?
This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2016-02. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02596932?
The interventions under investigation include: Standard Protocol for intrapartum glucose management (OTHER), Experimental Protocol for intrapartum glucose management (OTHER).
Who is sponsoring clinical trial NCT02596932?
This trial is sponsored by Women and Infants Hospital of Rhode Island, which has 65 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02596932's enrollment target sits among peer trials
76 1062nd of 2000 higher than 932 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia